Biotech startups that raised Series A in London, United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Alchemab Therapeutics | London | Series A | $33.6M | 2026-07-09 |
| Apoha | London | Series A | $36.0M | 2026-06-03 |
| Verdiva Bio | London | Series A | $411.0M | 2025-01-09 |
| Puraffinity | London | Series A | $8.8M | 2024-09-10 |
| Myricx Bio | London | Series A | $115.3M | 2024-07-08 |
| Baseimmune | London | Series A | $11.4M | 2024-02-26 |
| Mytos | London | Series A | $19.0M | 2023-11-30 |
| Umedeor | London | Series A | $12.5M | 2023-07-05 |
8 rows of the CSV in 5 of its 18 columns.
- The 43 biotech startups in London, United Kingdom whose last round is Series A have raised $1.3B in total.
- 6 of them closed their most recent round in the last 12 months, $225.1M combined.
- The largest of those rounds is RQ Bio's $112.5M Series A, dated June 2026.
- The most recent is R1 Therapeutics' $3.0M Series A on 30 September 2026.
- RA Capital Management is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 30 companies (70%).
- 33% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (58% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 43| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| Verdiva Bio | Verdiva Bio develops treatments for patients with obesity and cardiometabolic diseases. | Biotech | Series A | $411.0M | 2025-01-09 | $411.0M | General Atlantic, RA Capital Management, OrbiMed +1 | 11 to 50 | 2024 |
Table 1. Biotech startups that raised Series A in London, United Kingdom: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 43.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| 2 | Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
Table 2. Biotech startups that raised Series A in London, United Kingdom: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator | Boston, United States | 2 | 5% | 1 | Alchemab Therapeutics |
| 2 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 2 | 5% | 1 | Apoha |
| 3 | IQ Capital | Venture capital firm | London, United Kingdom | 2 | 5% | ||
| 4 | SV Health Investors | Private equity firm | Boston, United States | 1 | 2% | 1 | Alchemab Therapeutics |
| 5 | DHVC | Venture capital firm | Palo Alto, United States | 1 | 2% | 1 | Alchemab Therapeutics |
| 6 | DCVC | Venture capital firm | Palo Alto, United States | 1 | 2% | 1 | Alchemab Therapeutics |
| 7 | Dementia Discovery Fund | Venture capital firm | London, United Kingdom | 1 | 2% | 1 | Alchemab Therapeutics |
| 8 | Plug and Play | Startup accelerator | Sunnyvale, United States | 1 | 2% | 1 | Apoha |
| 9 | Intel Ignite | Startup accelerator | Tel Aviv, Israel | 1 | 2% | 1 | Apoha |
| 10 | Nucleus Capital | Venture capital firm | Berlin, Germany | 1 | 2% | 1 | Apoha |
| 11 | Wilbe | Entrepreneurship program | London, United Kingdom | 1 | 2% | 1 | Apoha |
| 12 | General Atlantic | Private equity firm | New York, United States | 1 | 2% | ||
| 13 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 1 | 2% | ||
| 14 | OrbiMed | Private equity firm | New York, United States | 1 | 2% | ||
| 15 | Octopus Ventures | Venture capital firm | London, United Kingdom | 1 | 2% |
Table 3. Biotech startups that raised Series A in London, United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 30 | 70% | $1.2B |
| Software | 8 | 19% | $121.1M |
| Hardware | 6 | 14% | $102.6M |
| Artificial intelligence | 3 | 7% | $87.0M |
| Fintech | 2 | 5% | |
| Education | 1 | 2% | |
| Cybersecurity | 1 | 2% |
Table 4. Biotech startups that raised Series A in London, United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 43 | 100% | $15.0M |
Table 5. Biotech startups that raised Series A in London, United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 17% | $3.0M |
| July 2026 | 1 | 17% | $33.6M |
| June 2026 | 2 | 33% | $148.5M |
| March 2026 | 1 | 17% | $15.0M |
| January 2026 | 1 | 17% | $25.0M |
Table 6. Biotech startups that raised Series A in London, United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 14% | $225.1M |
| 2025 | 6 | 14% | $627.0M |
| 2024 | 5 | 12% | $188.6M |
| 2023 | 7 | 16% | $129.4M |
| 2022 | 5 | 12% | $87.9M |
| 2021 | 3 | 7% | $89.5M |
Table 7. Biotech startups that raised Series A in London, United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 4 | 9% |
| 2020 to 2022 | 10 | 23% |
| 2015 to 2019 | 18 | 42% |
| 2010 to 2014 | 8 | 19% |
| Before 2010 | 3 | 7% |
Table 8. Biotech startups that raised Series A in London, United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 12 | 28% |
| 11 to 50 | 25 | 58% |
| 51 to 100 | 5 | 12% |
| 251 to 500 | 1 | 2% |
Table 9. Biotech startups that raised Series A in London, United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in London, United Kingdom. On 16 November 2026 that is 43 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 43 rows: 4 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in London, United Kingdom whose last round is Series A are on the list?
- 43, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 43 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.